|
| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 2074.73 | 2042.63 | 2082.31 |
| 60日平均 | 120日平均 | 260日平均 |
| 2188.30 | 1973.24 | 1865.10 |
| Date | Price | Change% |
| 2025/01/21 | 2112.39 | 0.36% |
| 2025/01/20 | 2104.73 | 1.81% |
| 2025/01/17 | 2067.27 | 0.78% |
| 2025/01/16 | 2051.35 | 0.66% |
| 2025/01/15 | 2037.93 | -1.82% |
| 2025/01/14 | 2075.76 | 4.71% |
| 2025/01/13 | 1982.46 | 0.36% |
| 2025/01/10 | 1975.3 | -1.76% |
| 2025/01/09 | 2010.66 | 0.11% |
| 2025/01/08 | 2008.44 | -0.98% |
| 2025/01/07 | 2028.36 | 0.70% |
| 2025/01/06 | 2014.19 | -0.09% |
| 2025/01/03 | 2015.97 | -2.16% |
| 2025/01/02 | 2060.44 | -3.58% |
| 2025/01/01 | 2136.92 | -0.22% |
| 2024/12/31 | 2141.6 | -2.93% |
| 2024/12/30 | 2206.29 | 0.06% |
| 2024/12/27 | 2204.9 | -0.22% |
| 2024/12/26 | 2209.85 | 0.39% |
| 2024/12/25 | 2201.3 | -0.55% |
相關基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 創業板指指數 | 25.47% | 19.88% | 42.61% | 17.22% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | -3.39% | 6.14% | 19.72% | -1.01% |
| 聯博中國A股基金-A2類型/美元 | -5.54% | 5.94% | 14.77% | -1.12% |
| 聯博中國A股基金-A2類型/人民幣 | -2.84% | 6.48% | 16.70% | -1.34% |
| 富達中國聚焦基金/美元 | -5.68% | 5.59% | 17.50% | -0.49% |
| 法巴中國股票基金-C股/美元 | -0.62% | 11.26% | 23.73% | 0.18% |
| 安聯中國策略基金/台幣 | -2.50% | 7.27% | 20.55% | -0.11% |
| 安聯中國股票基金-A股/配息/美元 | -8.26% | 7.79% | 20.74% | -0.85% |
| 霸菱香港中國基金-A類/配息/歐元 | -4.74% | 13.22% | 26.35% | -0.17% |
| 霸菱香港中國基金-A類/配息/美元 | -9.31% | 7.41% | 19.80% | -0.98% |
| 霸菱香港中國基金-A類/配息/英鎊 | -3.06% | 13.70% | 24.46% | 1.73% |
| 貝萊德中國基金A2/美元 | -5.93% | 8.70% | 23.06% | -1.02% |
| 貝萊德中國基金A2-歐元避險 | -6.52% | 7.40% | 20.69% | -1.30% |
| 貝萊德中國基金A2-澳幣避險 | -6.19% | 7.35% | 20.72% | -1.22% |
| 群益華夏盛世基金/台幣 | -2.55% | 0.46% | 11.45% | -2.74% |
| 群益華夏盛世基金/美元 | -4.71% | 0.23% | 6.83% | -2.83% |
| 群益華夏盛世基金/人民幣 | -1.94% | 0.87% | 8.64% | -2.76% |
| 群益中國新機會基金/台幣 | -2.99% | -0.31% | 6.40% | -1.82% |
| 群益中國新機會基金/美元 | -5.16% | -0.65% | 1.94% | -1.98% |
| 群益中國新機會基金/人民幣 | -2.40% | -0.02% | 3.66% | -1.90% |
| DWS投資中國股票基金E2/美元 | -5.73% | 10.28% | 26.31% | 0.03% |
| DWS投資中國股票基金A2/美元 | -5.95% | 9.79% | 25.18% | -0.02% |
| DWS投資中國股票基金FC/歐元 | -1.68% | 15.30% | 32.14% | -0.04% |
| DWS投資中國股票基金LC/歐元 | -1.89% | 14.84% | 31.06% | -0.09% |
| 瀚亞中國基金/台幣 | -5.02% | 1.16% | 8.34% | -2.18% |
| 瀚亞中國股票基金/美元 | -5.63% | 9.86% | 25.14% | 0.42% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | 2.01% | 20.06% | 33.93% | -2.24% |
| 愛德蒙得洛希爾中國基金(A)/美元 | -2.96% | 13.13% | 27.17% | -2.76% |
| 歐義銳榮中國股票基金-R/歐元 | 1.23% | 15.62% | 31.24% | -1.91% |
| 歐義銳榮中國股票基金-R2/美元 | -3.70% | 8.96% | 24.61% | -2.43% |
| 首域盈信中國核心基金/美元 | -8.30% | 9.88% | 20.62% | -1.29% |
| 富蘭克林華美中國消費基金/台幣 | -2.68% | 2.40% | 19.76% | -0.30% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | -2.72% | 1.71% | 21.96% | -0.67% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | -2.94% | 1.15% | 17.83% | -1.73% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | -4.98% | 1.42% | 16.87% | -0.81% |
| 復華華人世紀基金/台幣 | 8.43% | 10.79% | 44.56% | 3.03% |
| 復華大中華中小策略基金/台幣 | -1.55% | 2.76% | 19.57% | -0.78% |
| 匯豐中國動力基金-台幣 | -2.94% | 6.46% | 25.62% | -0.89% |
| 匯豐中國股票基金AD/美元 | -6.17% | 5.17% | 21.55% | -0.67% |
| 景順中國基金-A股/美元 | -5.94% | 10.89% | 21.53% | -0.78% |
| 景順中國基金-A股/歐元對沖 | -6.75% | 9.12% | 18.96% | -1.00% |
| 景順中國基金-A股/澳幣對沖 | -6.24% | 9.39% | 19.34% | -0.72% |
| 摩根中國基金-A股/分派/美元 | -8.56% | 9.90% | 19.62% | -1.67% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 5.12% | 23.72% | 34.66% | 0.41% |
| 野村中國機會基金/台幣 | -5.87% | 1.46% | 18.02% | 0.16% |
| 鋒裕匯理-中國股票基金-A2/美元 | -5.31% | 11.46% | 19.32% | -0.08% |
| 鋒裕匯理-中國股票基金-B2/美元 | -5.42% | 11.17% | 18.60% | 0.00% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.10% | 16.67% | 24.80% | -0.48% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | -2.19% | 5.73% | 12.16% | -0.37% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | -6.74% | 5.95% | 15.38% | -0.59% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | -7.22% | 4.86% | 13.06% | -0.77% |
| 元大新中國基金/台幣 | -1.88% | 2.81% | 18.72% | 2.05% |
| ( 中國基金 ) | -3.79% | 6.38% | 17.05% | -1.65% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|